2L0P | B:4-47; B:4-47 | SOLUTION STRUCTURE OF HUMAN APO-S100A1 PROTEIN BY NMR SPECTROSCOPY |
1MQ1 | B:3-46; B:3-46 | CA2+-S100B-TRTK-12 COMPLEX |
1UWO | B:3-46; B:3-46 | CALCIUM FORM OF HUMAN S100B, NMR, 20 STRUCTURES |
2PRU | B:3-46; B:3-46 | NMR STRUCTURE OF HUMAN APOS100B AT 10C |
1OZO | B:4-47; B:4-47 | THREE-DIMENSIONAL SOLUTION STRUCTURE OF APO-S100P PROTEIN DETERMINED BY NMR SPECTROSCOPY |
2RGI | B:5-48; B:5-48 | CRYSTAL STRUCTURE OF CA2+-FREE S100A2 AT 1.6 A RESOLUTION |
1KSO | B:5-48; B:5-48 | CRYSTAL STRUCTURE OF APO S100A3 |
3NSI | B:5-48; B:5-48 | CRYSTAL STRUCTURE OF THE POST-REFOLDED S100A3 PROTEIN EXPRESSED IN INSECT CELL |
3NSK | B:5-48; B:5-48 | CRYSTAL STRUCTURE OF THE POST-REFOLDED S100A3 R51A MUTANT EXPRESSED IN INSECT CELL |
3NSL | F:5-48; F:5-48; F:5-48; F:5-48; F:5-48; F:5-48 | CRYSTAL STRUCTURE OF S100A3 C30A+C68A DOUBLE MUTANT EXPRESSED IN INSECT CELL |
3NSO | B:5-48; B:5-48 | CRYSTAL STRUCTURE OF S100A3 PROTEIN EXPRESSED IN INSECT CELL |
2Q91 | B:5-48; B:5-48 | STRUCTURE OF THE CA2+-BOUND ACTIVATED FORM OF THE S100A4 METASTASIS FACTOR |
3KO0 | T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48; T:5-48 | STRUCTURE OF THE TFP-CA2+-BOUND ACTIVATED FORM OF THE S100A4 METASTASIS FACTOR |
3M0W | J:5-46; J:5-46; J:5-46; J:5-46; J:5-46; J:5-46; J:5-46; J:5-46; J:5-46; J:5-46 | STRUCTURE OF S100A4 WITH PCP |
2KAX | B:5-43; B:5-43 | SOLUTION STRUCTURE AND DYNAMICS OF S100A5 IN THE APO AND CA2+ -BOUND STATES |
2KAY | B:5-43; B:5-43 | SOLUTION STRUCTURE AND DYNAMICS OF S100A5 IN THE CA2+ -BOUND STATES |
1K8U | A:5-44 | CRYSTAL STRUCTURE OF CALCIUM-FREE (OR APO) HUMAN S100A6; CYS3MET MUTANT (SELENOMETHIONINE DERIVATIVE) |
1K96 | A:5-44 | CRYSTAL STRUCTURE OF CALCIUM BOUND HUMAN S100A6 |
1K9P | A:5-44 | CRYSTAL STRUCTURE OF CALCIUM FREE (OR APO) HUMAN S100A6 |
1PSR | B:5-45; B:5-45 | HUMAN PSORIASIN (S100A7) |
2PSR | A:5-45 | HUMAN PSORIASIN (S100A7) CA2+ AND ZN2+ BOUND FORM (CRYSTAL FORM II) |
2WND | A:5-45 | STRUCTURE OF AN S100A7 TRIPLE MUTANT |
2WOR | A:5-45 | CO-STRUCTURE OF S100A7 WITH 1,8 ANS |
2WOS | A:5-45 | STRUCTURE OF HUMAN S100A7 IN COMPLEX WITH 2,6 ANS |
3PSR | B:5-45; B:5-45 | HUMAN PSORIASIN (S100A7) CA2+ BOUND FORM (CRYSTAL FORM I) |
1MR8 | B:5-48; B:5-48 | MIGRATION INHIBITORY FACTOR-RELATED PROTEIN 8 FROM HUMAN |
1XK4 | J:5-48; J:5-48; J:5-48; J:5-48; J:5-48; J:5-48; L:8-51; L:8-51; L:8-51; L:8-51; L:8-51; L:8-51 | CRYSTAL STRUCTURE OF HUMAN CALPROTECTIN(S100A8/S100A9) |
1V50 | A:8-17 | SOLUTION STRUCTURE OF PHOSPHORYLATED N-TERMINAL FRAGMENT OF S100C/A11 PROTEIN |
1ODB | F:3-46; F:3-46; F:3-46; F:3-46; F:3-46; F:3-46 | THE CRYSTAL STRUCTURE OF HUMAN S100A12 - COPPER COMPLEX |
2WC8 | D:3-46; D:3-46; D:3-46; D:3-46 | S100A12 COMPLEX WITH ZINC IN THE ABSENCE OF CALCIUM |
2WCB | B:3-46; B:3-46 | S100A12 COMPLEX WITH ZINC IN THE ABSENCE OF CALCIUM |
2WCE | B:3-46; B:3-46 | CALCIUM-FREE (APO) S100A12 |
2WCF | F:3-46; F:3-46; F:3-46; F:3-46; F:3-46; F:3-46 | CALCIUM-FREE (APO) S100A12 |
1YUS | B:9-52; B:9-52 | SOLUTION STRUCTURE OF APO-S100A13 |
1YUT | B:9-52; B:9-52 | SOLUTION STRUCTURE OF CALCIUM-S100A13 (MINIMIZED MEAN STRUCTURE) |
1YUU | B:9-52; B:9-52 | SOLUTION STRUCTURE OF CALCIUM-S100A13 |
2K8M | C:9-52; C:9-52 | S100A13-C2A BINARY COMPLEX STRUCTURE |
2KI4 | C:9-52; C:9-52 | FGF1-S100A13 COMPLEX STRUCTURE: KEY COMPONENT IN NON-CLASSICAL PATH WAY OF FGF1 |
2KI6 | D:9-52; D:9-52 | THE FGF1-S100A13-C2A HETERO-HEXAMERIC COMPLEX STRUCTURE: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR FGF1 SECRETION |
2KOT | B:9-52; B:9-52 | SOLUTION STRUCTURE OF S100A13 WITH A DRUG AMLEXANOX |
2L5X | C:9-52; C:9-52 | SOLUTION STRUCTURE OF IL1A-S100A13 COMPLEX |